Corcept Therapeutics Incorporated (CORT)
NASDAQ · Healthcare
Corcept Therapeutics Incorporated Net Income 2009–2025
Corcept Therapeutics Incorporated annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Corcept Therapeutics Incorporated net income for the quarter ending March 31, 2026 was -31.8 M, a 254.58% decrease year-over-year.
- Corcept Therapeutics Incorporated net income for the twelve months ending March 31, 2026 was 43.6 M, a 69.26% decrease year-over-year.
- Corcept Therapeutics Incorporated annual net income for 2025 was 99.7 M, a 29.43% decrease from 2024.
- Corcept Therapeutics Incorporated annual net income for 2024 was 141.2 M, a 33.04% increase from 2023.
- Corcept Therapeutics Incorporated annual net income for 2023 was 106.1 M, a 4.66% increase from 2022.
- Corcept Therapeutics Incorporated annual net income for 2022 was 101.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corcept Therapeutics Incorporated Net Income — FAQ
Corcept Therapeutics Incorporated (CORT) net income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Corcept Therapeutics Incorporated's net income?
Corcept Therapeutics Incorporated (CORT) reported net income of $100M for fiscal 2025.
Where can I see CORT's net income history?
The chart and table above show Corcept Therapeutics Incorporated's net income by year and by quarter, including the growth rate.